American Banking and Market News logo

The Latest Headlines at American Banking and Market News

Image about 19,941 Shares in Silk Road Medical, Inc (NASDAQ:SILK) Acquired by Graham Capital Management L.P.

19,941 Shares in Silk Road Medical, Inc (NASDAQ:SILK) Acquired by Graham Capital Management L.P.

Graham Capital Management L.P. purchased a new position in shares of Silk Road Medical, Inc (NASDAQ:SILK – Free Report) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor... More of this article »
Image about 95,363 Shares in Ocular Therapeutix, Inc. (NASDAQ:OCUL) Acquired by Graham Capital Management L.P.

95,363 Shares in Ocular Therapeutix, Inc. (NASDAQ:OCUL) Acquired by Graham Capital Management L.P.

Graham Capital Management L.P. bought a new position in shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and... More of this article »
Image about Graham Capital Management L.P. Makes New Investment in FARO Technologies, Inc. (NASDAQ:FARO)

Graham Capital Management L.P. Makes New Investment in FARO Technologies, Inc. (NASDAQ:FARO)

Graham Capital Management L.P. purchased a new position in shares of FARO Technologies, Inc. (NASDAQ:FARO – Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 22,853... More of this article »
Image about Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target Raised to $425.00

Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target Raised to $425.00

Madrigal Pharmaceuticals (NASDAQ:MDGL – Free Report) had its price objective upped by HC Wainwright from $405.00 to $425.00 in a research report released on Friday, Benzinga reports. HC Wainwright currently has a buy rating on... More of this article »
Image about Graham Capital Management L.P. Sells 5,140 Shares of Westamerica Bancorporation (NASDAQ:WABC)

Graham Capital Management L.P. Sells 5,140 Shares of Westamerica Bancorporation (NASDAQ:WABC)

Graham Capital Management L.P. lessened its holdings in Westamerica Bancorporation (NASDAQ:WABC – Free Report) by 39.1% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission... More of this article »
Image about Walleye Capital LLC Takes $1.37 Million Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)

Walleye Capital LLC Takes $1.37 Million Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)

Walleye Capital LLC purchased a new stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 46,244 shares of the company’s... More of this article »
Image about Comerica Bank Has $4.17 Million Stake in UniFirst Co. (NYSE:UNF)

Comerica Bank Has $4.17 Million Stake in UniFirst Co. (NYSE:UNF)

Comerica Bank decreased its position in UniFirst Co. (NYSE:UNF – Free Report) by 82.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm... More of this article »
Image about TD Cowen Raises Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target to $390.00

TD Cowen Raises Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target to $390.00

Madrigal Pharmaceuticals (NASDAQ:MDGL – Free Report) had its price objective lifted by TD Cowen from $349.00 to $390.00 in a research report sent to investors on Friday morning, Benzinga reports. TD Cowen currently has an outperform... More of this article »
Image about Dollar General (NYSE:DG) Price Target Raised to $165.00

Dollar General (NYSE:DG) Price Target Raised to $165.00

Dollar General (NYSE:DG – Free Report) had its target price raised by Raymond James from $150.00 to $165.00 in a research report released on Friday morning, Benzinga reports. They currently have an outperform rating on the stock. A... More of this article »
Image about Walleye Capital LLC Acquires 92,410 Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA)

Walleye Capital LLC Acquires 92,410 Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA)

Walleye Capital LLC grew its position in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Free Report) by 342.8% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 119,364... More of this article »
Image about Walleye Capital LLC Sells 107,479 Shares of FTAC Emerald Acquisition Corp. (NASDAQ:EMLD)

Walleye Capital LLC Sells 107,479 Shares of FTAC Emerald Acquisition Corp. (NASDAQ:EMLD)

Walleye Capital LLC lowered its position in shares of FTAC Emerald Acquisition Corp. (NASDAQ:EMLD – Free Report) by 45.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission.... More of this article »
Image about Walleye Capital LLC Has $1.54 Million Stake in FutureTech II Acquisition Corp. (NASDAQ:FTII)

Walleye Capital LLC Has $1.54 Million Stake in FutureTech II Acquisition Corp. (NASDAQ:FTII)

Walleye Capital LLC increased its position in shares of FutureTech II Acquisition Corp. (NASDAQ:FTII – Free Report) by 221.0% during the third quarter, according to the company in its most recent disclosure with the Securities... More of this article »
Image about Comerica Bank Decreases Stock Position in Williams-Sonoma, Inc. (NYSE:WSM)

Comerica Bank Decreases Stock Position in Williams-Sonoma, Inc. (NYSE:WSM)

Comerica Bank cut its holdings in Williams-Sonoma, Inc. (NYSE:WSM – Free Report) by 85.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned... More of this article »
Image about Walleye Capital LLC Acquires 787,172 Shares of Chijet Motor Company, Inc. (NASDAQ:CJET)

Walleye Capital LLC Acquires 787,172 Shares of Chijet Motor Company, Inc. (NASDAQ:CJET)

Walleye Capital LLC increased its holdings in Chijet Motor Company, Inc. (NASDAQ:CJET – Free Report) by 772.1% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange... More of this article »
Image about Madrigal Pharmaceuticals (NASDAQ:MDGL) PT Raised to $389.00

Madrigal Pharmaceuticals (NASDAQ:MDGL) PT Raised to $389.00

Madrigal Pharmaceuticals (NASDAQ:MDGL – Free Report) had its price objective upped by Citigroup from $382.00 to $389.00 in a report published on Friday, Benzinga reports. They currently have a buy rating on the biopharmaceutical... More of this article »